Trial intelligence / Profile preview

Pamidronate for pain in adult chronic nonbacterial osteitis

2020-001068-27Phase 4Active

Sponsor
Leiden University Medical Center
Start
Nov 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in Chronic nonbacterial osteomyelitis (CRMO) comparing Pamidronate with Placebo (2 arms). Primary endpoint: Change in maximal pain score. Started Nov 2020; status: active.

02

Drugs

pamidronate
03

Conditions

Chronic nonbacterial osteomyelitis (CRMO)

Beyond the preview

Go deeper on 2020-001068-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-001068-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call